Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.708
Neutral
RSI(14)
59.325
Neutral
STOCH(KDJ)(9,3,3)
42.803
Neutral
ATR(14)
7.706
High Vlolatility
CCI(14)
-12.395
Neutral
Williams %R
41.308
Buy
TRIX(12,20)
0.378
Sell
StochRSI(14)
45.879
Buy
Search
Cencora Inc
CORAdd to Watchlist
305.030USD
+4.450+1.48%
Close 07-23 16:00（ET）Quotes delayed by 15 min
59.35BMarket Cap
23.26P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+1.48%
5 Days
-0.96%
1 Month
+8.51%
6 Months
-13.71%
Year to Date
-9.69%
1 Year
+3.95%
Key Figures
299.300Open
306.005High
1.17MVolume
23.26P/E TTM
15.68P/E Dynamic
2.300Dividend TTM
0.60%Turnover Ratio
300.580Prev. Close
298.444Low
173.30MTurnover
38.19P/E Static
17.47P/B
0.75%Div Yield TTM
3.34%ROA
377.54052wk High
0.76Volume Ratio
1.55BNet Profit
194.56MShares
13.1155EPS TTM
0.60Beta
115.58%ROE
244.82052wk Low
2.52%Amplitude
4.26%Gross Margin
59.35BMarket Cap
3.93Reward/Risk
1.44%Risk Rate
TradingKey Stock Score of Cencora Inc
Currency: USD Updated: 2026-07-23Key Insights
Cencora Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 8 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 352.43.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cencora Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
27°C
Very Low
Very High
Neutral
Cencora Inc Highlights
StrengthsRisks
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 321.33B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.56% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 28.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 28.12%.
Undervalued
The company’s latest PE is 23.26, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 188.32M shares, increasing 0.50% quarter-over-quarter.
Held by Manning & Napier Group, LLC
Star Investor Manning & Napier Group, LLC holds 95.28K shares of this stock.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
352.426
Target Price
+16.29%
Upside Space
Cencora Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
16
analysts
Buy
Current Rating
352.426
Target Price
+16.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Cencora Inc
COR
16
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
304.120
Buy
MA10
303.701
Buy
MA20
298.736
Buy
MA50
282.067
Buy
MA100
301.989
Buy
MA200
324.505
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cencora Inc Info
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Ticker SymbolCOR
CompanyCencora Inc
CEOMauch (Robert P)
Websitehttps://www.cencora.com/
Shareholders
Related Instruments
-1.77%
+8.73%
+0.22%
-1.08%
+7.39%
+3.22%
-2.54%
+0.18%
+1.33%
-2.54%
+0.46%
+1.44%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%Popular Instruments
FAQs
What is the current price of Cencora Inc (COR)?
The current price of Cencora Inc (COR) is 305.03.
What is the symbol of Cencora Inc?
The ticker symbol of Cencora Inc is COR.
What is the 52-week high of Cencora Inc?
The 52-week high of Cencora Inc is 377.54.
What is the 52-week low of Cencora Inc?
The 52-week low of Cencora Inc is 244.82.
What is the market capitalization of Cencora Inc?
The market capitalization of Cencora Inc is 59.35B.
Is Cencora Inc (COR) currently rated as Buy, Hold, or Sell?
According to analysts, Cencora Inc (COR) has an overall rating of Buy, with a price target of 352.43.
What is the Earnings Per Share (EPS TTM) of Cencora Inc (COR)?
The Earnings Per Share (EPS TTM) of Cencora Inc (COR) is 8.02.